Francesco Grossi (F Grossi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Cancer immunology, immunotherapy : CII

Pharmaceutics

JCO precision oncology

Vaccines

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Sep 01 2018

Italy

Director :: Medical Oncology Unit

Publications

Gianpiero Fasola, Maria C Barducci, Valeria D Tozzi, Luigi Cavanna, Saverio Cinieri, Francesco Perrone, Carmine Pinto, Antonio Russo, Anna Sapino, Francesco Grossi, Giuseppe Aprile
Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific Societies. JCO precision oncology 7 (2023)
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica Teresa Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Marina Chiara Garassino, Andrea Botticelli, Alain J Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel Laurence Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo Antonio Ascierto, Corrado Ficorella, David James Pinato
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Marina-Chiara Garassino, Shirish M Gadgeel, Giovanna Speranza, Enriqueta Felip Font, Emilio Esteban, Manuel Dómine, Maximilian J Hochmair, Steven Francis Powell, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Takayasu Kurata, Jhanelle E Gray, Paul Schwarzenberger, Erin Jensen, M Catherine Pietanza, Delvys Rodriguez Abreu
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alice Indini, Erika Rijavec, Michele Ghidini, Alessio Cortellini, Francesco Grossi
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics 13 (5) (2021)
Diana Gulei, Alice Indini, Carmen Jerónimo, Cristina-Adela Iuga, Francesco Grossi
Cancer Mechanisms and Emerging Therapies. Pharmaceutics 13 (7) (2021)
Marco Russano, Alessio Cortellini, Raffaele Giusti, Alessandro Russo, Federica Zoratto, Francesca Rastelli, Alain Gelibter, Rita Chiari, Olga Nigro, Michele De Tursi, Sergio Bracarda, Stefania Gori, Francesco Grossi, Melissa Bersanelli, Lorenzo Calvetti, Vincenzo Di Noia, Mario Scartozzi, Massimo Di Maio, Paolo Bossi, Alfredo Falcone, Fabrizio Citarella, Francesco Pantano, Corrado Ficorella, Marco Filetti, Vincenzo Adamo, Enzo Veltri, Federica Pergolesi, Mario Alberto Occhipinti, Linda Nicolardi, Alessandro Tuzi, Pietro Di Marino, Serena Macrini, Alessandro Inno, Michele Ghidini, Sebastiano Buti, Giuseppe Aprile, Eleonora Lai, Marco Audisio, Salvatore Intagliata, Riccardo Marconcini, Davide Brocco, Giampiero Porzio, Marta Piras, Erika Rijavec, Francesca Simionato, Clara Natoli, Marcello Tiseo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. Cancer immunology, immunotherapy : CII (2021)
Alice Indini, Athanasia Tourlaki, Francesco Grossi, Donatella Gambini, Lucia Brambilla
COVID-19 Vaccination in Patients with Classic Kaposi's Sarcoma. Vaccines 9 (6) (2021)
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers 13 (13) (2021)
Alice Indini, Fausto Roila, Francesco Grossi, Daniela Massi, Mario Mandala
Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review. International journal of molecular sciences 23 (1) (2021)
Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchiè, S Minetti, N Bardi, E Elia, A M Ansaldo, D Ferrara, E Rijavec, M G Dal Bello, Giovanni Rossi, F Biello, M Tagliamento, Angela Alama, Simona Coco, P Spallarossa, Franco Dallegri, Carlo Genova, Fabrizio Montecucco
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Aldo Bonaventura, Francesco Grossi, Fabrizio Montecucco
PCSK9 is a promising prognostic marker in patients with advanced NSCLC. Cancer immunology, immunotherapy : CII 69 (3) (2020)
Alice Indini, Monica Cattaneo, Michele Ghidini, Erika Rijavec, Claudia Bareggi, Barbara Galassi, Donatella Gambini, Rosalia Ceriani, Ferruccio Ceriotti, Emilio Berti, Francesco Grossi
Triage process for the assessment of coronavirus disease 2019-positive patients with cancer: The ONCOVID prospective study. Cancer 127 (7) (2020)
Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchiè, Silvia Minetti, Nicholas Bardi, Edoardo Elia, Anna Maria Ansaldo, Daniele Ferrara, Erika Rijavec, Maria Giovanna Dal Bello, Giovanni Rossi, Federica Biello, Marco Tagliamento, Angela Alama, Simona Coco, Paolo Spallarossa, Franco Dallegri, Carlo Genova, Fabrizio Montecucco
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer immunology, immunotherapy : CII 68 (8) (2019)

Francesco Grossi.css-eqlu8i{font-size:small;padding-left:4px;} (F Grossi)

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Grossi (F Grossi)